167. Femtech Boss! Sold “Female Viagra” for 1 Billion Then Took it Back - Cindy Eckert!

She started with Slate Pharmaceuticals, which redefined long acting testosterone treatment for men then moved to Sprout Pharmaceuticals which broke through with the first ever FDA-approved drug for low sexual desire in women — dubbed “female Viagra” by the media. After selling the company for $1B in 2015, she successfully fought to get the drug back and launch it on her own terms. Meet Cindy Eckert! Addyi - Filbanserin - The first FDA approved medication to treat the condition Hypoactive (low) Sexual Desire Disorder (HSDD), characterized as frustrating low libido, is the most common form of sexual dysfunction in premenopausal women. Though not fully understood, HSDD is believed to be caused by an imbalance of chemicals in the brain. Are we limiting women by “protecting them”? How did Addyi come into her life? Data on Addyi and breast cancer is coming out! Prescription versus supplements and what is “natural”? You make it look glam – but is it a slog? She wants to make 1 Billion of wealth for women! “Success comes from courage” – Cindy Eckert. https://addyi.com https://thepinkceiling.com https://www.instagram.com/cindypinkceo/ https://www.youtube.com/watch?v=DyuSZ80-kZI Love these interviews? Want to join them live with me? https://www.kellycaspersonmd.com/membership Our podcast sponsor is Bonafide Bonafide products help women embrace the natural changes that occur throughout all phases of life. Discount code for 20% off:NOTBROKEN Sales link: https://hellobonafide.com/notbroken --- Send in a voice message: https://podcasters.spotify.com/pod/show/kj-casperson/message Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.